PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wroblewski JJ et al. – Intravitreous pegaptanib offers a promising alternative as a treatment for macular edema secondary to BRVO.

Related Articles

Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09    Relevance Score: 69%

Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion
European Journal of Ophthalmology, 11/13/09    Relevance Score: 68%

Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09    Relevance Score: 68%

Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions
Retina, 11/17/09    Relevance Score: 66%

Improving intraocular lens power prediction in combined phacoemulsification and vitrectomy in eyes with macular oedema
Acta Ophthalmologica, 11/17/09    Relevance Score: 66%

Today in Ophthalmology...keeping you current

Comparison Between the plusoptiX and MTI Photoscreeners
Archives of Ophthalmology, 12/18/09

Contact Lens-Related Adverse Events and the Silicone Hydrogel Lenses and Daily Wear Care System Used
Archives of Ophthalmology, 12/18/09

Melanoma-Associated Retinopathy
Archives of Ophthalmology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address